​

Lexeo Therapeutics (LXEO) Stock Forecast, Price Target & Predictions

OverviewOwnershipFinancialsChart

LXEO Stock Forecast

Lexeo Therapeutics (LXEO) stock forecast, based on 5 Wall Street analysts, predicts a 12-month average price target of $28.00, with a high of $28.00 and a low of $28.00. This represents a 584.60% increase from the last price of $4.09.

- $6 $12 $18 $24 $30 High: $28 Avg: $28 Low: $28 Last Closed Price: $4.09

LXEO Stock Rating

Lexeo Therapeutics stock's rating consensus is Buy, based on 5 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 5 Buy (100.00%), 0 Hold (0.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 5 0 5 Strong Sell Sell Hold Buy Strong Buy

LXEO Price Target Upside V Benchmarks

TypeNameUpside
StockLexeo Therapeutics584.60%
SectorHealthcare Stocks 24.81%
IndustryBiotech Stocks 65.78%

Price Target Trends

1M3M12M
# Anlaysts--1
Avg Price Target--$28.00
Last Closing Price$4.09$4.09$4.09
Upside/Downside--584.60%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jun, 2534---7
May, 2534---7
Apr, 2534---7
Mar, 2534---7
Feb, 2534---7
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Jun 12, 2024Brian SkorneyRobert W. Baird$28.00$18.1953.93%584.60%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Jun 06, 2024H.C. WainwrightBuyinitialise
Mar 12, 2024RBC CapitalOutperformOutperformhold

Financial Forecast

EPS Forecast

$-11 $-9 $-7 $-5 $-3 $-1 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-2.49$-3.09----
Avg Forecast$-6.66$-3.12$-3.01$-3.12$-3.56$-2.81
High Forecast$-3.95$-3.01$-1.94$-1.78$-3.56$-2.81
Low Forecast$-10.30$-3.29$-4.16$-4.63$-3.56$-2.81
Surprise %-62.61%-0.96%----

Revenue Forecast

$50M $110M $170M $230M $290M $350M Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported------
Avg Forecast-$4.50M$1.13M-$57.00M$321.00M
High Forecast-$4.50M$1.13M-$57.00M$321.00M
Low Forecast-$4.50M$1.13M-$57.00M$321.00M
Surprise %------

Net Income Forecast

$-300M $-240M $-180M $-120M $-60M $0 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-66.39M$-98.33M----
Avg Forecast$-189.88M$-86.60M$-104.22M$-89.22M$-94.73M$-74.88M
High Forecast$-105.25M$-80.23M$-51.61M$-47.45M$-94.73M$-74.88M
Low Forecast$-274.51M$-87.64M$-110.72M$-123.49M$-94.73M$-74.88M
Surprise %-65.03%13.55%----

LXEO Forecast FAQ

Is Lexeo Therapeutics stock a buy?

Lexeo Therapeutics stock has a consensus rating of Buy, based on 5 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 5 Buy, 0 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Lexeo Therapeutics is a favorable investment for most analysts.

What is Lexeo Therapeutics's price target?

Lexeo Therapeutics's price target, set by 5 Wall Street analysts, averages $28 over the next 12 months. The price target range spans from $28 at the low end to $28 at the high end, suggesting a potential 584.60% change from the previous closing price of $4.09.

How does Lexeo Therapeutics stock forecast compare to its benchmarks?

Lexeo Therapeutics's stock forecast shows a 584.60% upside, outperforming the average forecast for the healthcare stocks sector (24.81%) and outperforming the biotech stocks industry (65.78%).

What is the breakdown of analyst ratings for Lexeo Therapeutics over the past three months?

  • June 2025: 42.86% Strong Buy, 57.14% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • May 2025: 42.86% Strong Buy, 57.14% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • April 2025: 42.86% Strong Buy, 57.14% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is Lexeo Therapeutics’s EPS forecast?

Lexeo Therapeutics's average annual EPS forecast for its fiscal year ending in December 2025 is $-3.01, marking a -2.59% decrease from the reported $-3.09 in 2024. Estimates for the following years are $-3.12 in 2026, $-3.56 in 2027, and $-2.81 in 2028.

What is Lexeo Therapeutics’s revenue forecast?

Lexeo Therapeutics's average annual revenue forecast for its fiscal year ending in December 2025 is $1.12M, reflecting a 0% decrease from the reported $0 in 2024. The forecast for 2026 is $0, followed by $57M for 2027, and $321M for 2028.

What is Lexeo Therapeutics’s net income forecast?

Lexeo Therapeutics's net income forecast for the fiscal year ending in December 2025 stands at $-104M, representing an 5.98% increase from the reported $-98.333M in 2024. Projections indicate $-89.223M in 2026, $-94.728M in 2027, and $-74.876M in 2028.